EXT] Subtractive Immunization

Yes, please propose several times or later I send you my available ! Great!

Laura Bover, PhD
Professor
Director Monoclonal Antibody Core Facility
University of Texas M.D.Anderson Cancer Center
Associate member of The University of Texas Graduate School of Biomedical
Sciences at Houston
Member of the Scientific Review Committee 2 (former CRC 2)
Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St<x-apple-data-detectors://1/1> Room 1SCR4.2021
Houston- TX 77054<x-apple-data-detectors://2/0>
T  713-563-3301<tel:713-563-3301>
F 713-563-3276<tel:713-563-3276>
<email obscured><email obscured>>

On Jul 30, 2020, at 7:53 AM, <email obscured>" <email obscured>> wrote:

WARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.

Ed and Laura

    Can we set up a time learn about subtractive immunization early next week?
    In the mean time I’ll or the cyclophosphamide.

ARG Discussion Forum Members,

    Does anyone else want to attend?

Frances


Frances Weis-Garcia, Ph.D.

Head
Bi-Institutional Antibody and Bioresource Core Facility

Associate Laboratory Member
Immunology Program

Memorial Sloan Kettering Cancer Center
1275 York Avenue, New York, NY 10065
T 646.888.2354   C 516.967.0656

ABCF-MSKCC
website<https://urldefense.com/v3/__https://www.mskcc.org/research-advantage/core-facilities/monoclonal-antibody-core-facility__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQavGbEqZ$
>

Adjunct Faculty
Center for Clinical and Translational Science

The Rockefeller University
1230 York Avenue, New York, NY 10065
T 212.327.7030

ABCF-RU
website<https://urldefense.com/v3/__https://www.rockefeller.edu/monoclonal/__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQStlvFdx$
>


Please note that this e-mail and any files transmitted with it may be
privileged, confidential, and protected from disclosure under applicable law.
If the reader of this message is not the intended recipient, or an employee or
agent responsible for delivering this message to the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying, or
other use of this communication or any of its attachments is strictly
prohibited.  If you have received this communication in error, please notify
the sender immediately by replying to this message and deleting this message,
any attachments, and all copies and backups from your computer.

=====================================================================

    Please note that this e-mail and any files transmitted from
    Memorial Sloan Kettering Cancer Center may be privileged, confidential,
    and protected from disclosure under applicable law. If the reader of
    this message is not the intended recipient, or an employee or agent
    responsible for delivering this message to the intended recipient,
    you are hereby notified that any reading, dissemination, distribution,
    copying, or other use of this communication or any of its attachments
    is strictly prohibited.  If you have received this communication in
    error, please notify the sender immediately by replying to this message
    and deleting this message, any attachments, and all copies and backups
    from your computer.

――
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/UGk03QWN9LUZhf49lemWo__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQUrtoCZq$
Leave group <email obscured>?Subject=Unsubscribe

The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.

Absolutely.

Frances

ZRC 1563
Office     646-888-2354
Mobile   516-967-0656


On 7/30/20, 10:18 AM, "Antibody Discussion Forum on behalf of Angel Sampson"
<email obscured> on behalf of <email obscured>> wrote:

    Dear all,

    Is it possible for me to join the Zoom call to learn more about subtractive
immunization. I have been wanting to try it here at UF.

    Kind regards,

    Angel

    Edith “Angel” Sampson, Ph.D.
    Monoclonal Antibody Scientific Director

    UF ICBR
    2033 Mowry Road, Gainesville, FL 32610
    Biotech.ufl.edu | Tel: 352.273.8039| Fax: 352.273.8070



    -----Original Message-----
    From: Antibody Discussion Forum <email obscured>> On Behalf Of
Bover,Laura
    Sent: Thursday, July 30, 2020 9:38 AM
    To: <email obscured>
    Subject: Re: [ABRF Ab Forum] [EXT] Subtractive Immunization

    [External Email]

    Yes, please propose several times or later I send you my available ! Great!

    Laura Bover, PhD
    Professor
    Director Monoclonal Antibody Core Facility University of Texas M.D.Anderson
Cancer Center Associate member of The University of Texas Graduate School of
Biomedical Sciences at Houston Member of the Scientific Review Committee 2
(former CRC 2) Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
    7455 Fannin St<x-apple-data-detectors://1/1> Room 1SCR4.2021
    Houston- TX 77054<x-apple-data-detectors://2/0>
    T  713-563-3301<tel:713-563-3301>
    F 713-563-3276<tel:713-563-3276>
    <email obscured><email obscured>>

    On Jul 30, 2020, at 7:53 AM, <email obscured>" <email obscured>>
wrote:

    WARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.

    Ed and Laura

        Can we set up a time learn about subtractive immunization early next
week?
        In the mean time I’ll or the cyclophosphamide.

    ARG Discussion Forum Members,

        Does anyone else want to attend?

    Frances


    Frances Weis-Garcia, Ph.D.

    Head
    Bi-Institutional Antibody and Bioresource Core Facility

    Associate Laboratory Member
    Immunology Program

    Memorial Sloan Kettering Cancer Center
    1275 York Avenue, New York, NY 10065
    T 646.888.2354   C 516.967.0656

    ABCF-MSKCC
website<https://urldefense.com/v3/__https://www.mskcc.org/research-advantage/core-facilities/monoclonal-antibody-core-facility__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQavGbEqZ$
>

    Adjunct Faculty
    Center for Clinical and Translational Science

    The Rockefeller University
    1230 York Avenue, New York, NY 10065
    T 212.327.7030

    ABCF-RU
website<https://urldefense.com/v3/__https://www.rockefeller.edu/monoclonal/__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQStlvFdx$
>


    Please note that this e-mail and any files transmitted with it may be
privileged, confidential, and protected from disclosure under applicable law.
If the reader of this message is not the intended recipient, or an employee or
agent responsible for delivering this message to the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying, or
other use of this communication or any of its attachments is strictly
prohibited.  If you have received this communication in error, please notify
the sender immediately by replying to this message and deleting this message,
any attachments, and all copies and backups from your computer.


    =====================================================================

        Please note that this e-mail and any files transmitted from
        Memorial Sloan Kettering Cancer Center may be privileged, confidential,
        and protected from disclosure under applicable law. If the reader of
        this message is not the intended recipient, or an employee or agent
        responsible for delivering this message to the intended recipient,
        you are hereby notified that any reading, dissemination, distribution,
        copying, or other use of this communication or any of its attachments
        is strictly prohibited.  If you have received this communication in
        error, please notify the sender immediately by replying to this message
        and deleting this message, any attachments, and all copies and backups
        from your computer.

    ――
    View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/UGk03QWN9LUZhf49lemWo__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQUrtoCZq$
    Leave group <email obscured>?Subject=Unsubscribe

    The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.

    ――
    View topic
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_2Ah9zjtxUijOERBGsq2mML&d=DwIFaQ&c=sJ6xIWYx-zLMB3EPkvcnVg&r=F6AO--4VYeLfDWXyalUQRQ&m=4iz1voPUApsW7XoXCeDbHEh3oVdv-G37GcJDCaOxbeA&s=hhSVRO1MsAk0UvQzbLnmFWUuZ96ZXVu_Rv1ybRTQqnM&e=
    Leave group <email obscured>?Subject=Unsubscribe


    ――
    View topic http://list.abrf.org/r/topic/5z9iGvqarHaHnBHHdaCRhs
    Leave group <email obscured>?Subject=Unsubscribe




    *** Only open attachments or links from trusted senders. Report phishing to
<email obscured> ***

=====================================================================

     Please note that this e-mail and any files transmitted from
     Memorial Sloan Kettering Cancer Center may be privileged, confidential,
     and protected from disclosure under applicable law. If the reader of
     this message is not the intended recipient, or an employee or agent
     responsible for delivering this message to the intended recipient,
     you are hereby notified that any reading, dissemination, distribution,
     copying, or other use of this communication or any of its attachments
     is strictly prohibited.  If you have received this communication in
     error, please notify the sender immediately by replying to this message
     and deleting this message, any attachments, and all copies and backups
     from your computer.